First Two Cases Of XDR-TB Confirmed In Botswana, Ministry Of Health Say
Main Category: TuberculosisAlso Included In: MRSA / Drug Resistance; HIV / AIDS; Respiratory / Asthma
Article Date: 18 Jan 2008 - 11:00 PDT
| Patient / Public: | ![]() |
5 (1 votes) |
| Healthcare Prof: | ![]() |
Botswana's Ministry of Health on Wednesday said it has confirmed the country's first two cases of extensively drug-resistant tuberculosis, which is resistant to the two most potent first-line treatments and some of the available second-line drugs, the AP/Google.com reports. The health ministry also said it has confirmed 100 cases of multi-drug resistant TB. XDR-TB can be "particularly lethal" in Southern Africa because it often affects people living with HIV/AIDS, the AP/Google.com reports (Motseta, AP/Google.com, 1/16).
According to a report released in November 2007 by the Forum for Collaborative HIV Research, about one-third of the approximately 40 million HIV-positive people worldwide also are living with TB. Deaths from HIV/TB coinfection are five times higher than deaths from TB alone, the report said. It found that about half of all new TB cases in sub-Saharan Africa occur among HIV-positive people and that HIV/TB coinfection could be fueling the increase in drug-resistant strains of TB. About 10% of people living with HIV/AIDS develop TB annually, according to the report. Approximately 90% of people living with HIV/AIDS will die within months of contracting TB, Stephen Lawn, a researcher at the University of Cape Town, said (Kaiser Daily HIV/AIDS Report, 11/2/07).
XDR-TB has been reported in other parts of the world, and a number of cases have been diagnosed in the former Soviet republics. In Southern Africa, more than 400 cases of the disease have been reported in South Africa, and a handful of cases have been diagnosed in Mozambique. Although health officials have said the disease likely has spread to neighboring countries like Swaziland and Lesotho, XDR-TB has not been diagnosed in other Southern African nations because of a lack of laboratory facilities. In addition to South Africa, Botswana is the only other country in Southern Africa with adequate laboratory capacity to diagnose XDR-TB, according to the AP/Google.com.
Batatu Tafa, permanent secretary of Botswana's health ministry, said health care workers who provide TB treatment should receive examinations if they develop any symptoms. Tafa also called on HIV-positive people in the country to receive TB screenings (AP/Google.com, 1/16).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our tuberculosis section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/94336.php>
APA
http://www.medicalnewstoday.com/releases/94336.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




